Administration of M. leprae Hsp65 interferes with the murine lupus progression.

The heat shock protein [Hsp] family guides several steps during protein synthesis, are abundant in prokaryotic and eukaryotic cells, and are highly conserved during evolution. The Hsp60 family is involved in assembly and transport of proteins, and is expressed at very high levels during autoimmunity...

Full description

Bibliographic Details
Main Authors: Eliana B Marengo, Luciana V de Moraes, Marcella Faria, Beatriz L Fernandes, Luciana V Carvalho, Denise V Tambourgi, Luiz V Rizzo, Fernanda C V Portaro, Antônio Carlos M Camargo, Osvaldo A Sant'anna
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2515089?pdf=render
id doaj-100cada456b14e88afe7a30fe07c9c28
record_format Article
spelling doaj-100cada456b14e88afe7a30fe07c9c282020-11-25T02:39:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-0138e302510.1371/journal.pone.0003025Administration of M. leprae Hsp65 interferes with the murine lupus progression.Eliana B MarengoLuciana V de MoraesMarcella FariaBeatriz L FernandesLuciana V CarvalhoDenise V TambourgiLuiz V RizzoFernanda C V PortaroAntônio Carlos M CamargoOsvaldo A Sant'annaThe heat shock protein [Hsp] family guides several steps during protein synthesis, are abundant in prokaryotic and eukaryotic cells, and are highly conserved during evolution. The Hsp60 family is involved in assembly and transport of proteins, and is expressed at very high levels during autoimmunity or autoinflammatory phenomena. Here, the pathophysiological role of the wild type [WT] and the point mutated K(409)A recombinant Hsp65 of M. leprae in an animal model of Systemic Lupus Erythematosus [SLE] was evaluated in vivo using the genetically homogeneous [NZBxNZW]F(1) mice. Anti-DNA and anti-Hsp65 antibodies responsiveness was individually measured during the animal's life span, and the mean survival time [MST] was determined. The treatment with WT abbreviates the MST in 46%, when compared to non-treated mice [p<0.001]. An increase in the IgG2a/IgG1 anti-DNA antibodies ratio was also observed in animals injected with the WT Hsp65. Incubation of BALB/c macrophages with F(1) serum from WT treated mice resulted in acute cell necrosis; treatment of these cells with serum from K(409)A treated mice did not cause any toxic effect. Moreover, the involvement of WT correlates with age and is dose-dependent. Our data suggest that Hsp65 may be a central molecule intervening in the progression of the SLE, and that the point mutated K(409)A recombinant immunogenic molecule, that counteracts the deleterious effect of WT, may act mitigating and delaying the development of SLE in treated mice. This study gives new insights into the general biological role of Hsp and the significant impact of environmental factors during the pathogenesis of this autoimmune process.http://europepmc.org/articles/PMC2515089?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Eliana B Marengo
Luciana V de Moraes
Marcella Faria
Beatriz L Fernandes
Luciana V Carvalho
Denise V Tambourgi
Luiz V Rizzo
Fernanda C V Portaro
Antônio Carlos M Camargo
Osvaldo A Sant'anna
spellingShingle Eliana B Marengo
Luciana V de Moraes
Marcella Faria
Beatriz L Fernandes
Luciana V Carvalho
Denise V Tambourgi
Luiz V Rizzo
Fernanda C V Portaro
Antônio Carlos M Camargo
Osvaldo A Sant'anna
Administration of M. leprae Hsp65 interferes with the murine lupus progression.
PLoS ONE
author_facet Eliana B Marengo
Luciana V de Moraes
Marcella Faria
Beatriz L Fernandes
Luciana V Carvalho
Denise V Tambourgi
Luiz V Rizzo
Fernanda C V Portaro
Antônio Carlos M Camargo
Osvaldo A Sant'anna
author_sort Eliana B Marengo
title Administration of M. leprae Hsp65 interferes with the murine lupus progression.
title_short Administration of M. leprae Hsp65 interferes with the murine lupus progression.
title_full Administration of M. leprae Hsp65 interferes with the murine lupus progression.
title_fullStr Administration of M. leprae Hsp65 interferes with the murine lupus progression.
title_full_unstemmed Administration of M. leprae Hsp65 interferes with the murine lupus progression.
title_sort administration of m. leprae hsp65 interferes with the murine lupus progression.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2008-01-01
description The heat shock protein [Hsp] family guides several steps during protein synthesis, are abundant in prokaryotic and eukaryotic cells, and are highly conserved during evolution. The Hsp60 family is involved in assembly and transport of proteins, and is expressed at very high levels during autoimmunity or autoinflammatory phenomena. Here, the pathophysiological role of the wild type [WT] and the point mutated K(409)A recombinant Hsp65 of M. leprae in an animal model of Systemic Lupus Erythematosus [SLE] was evaluated in vivo using the genetically homogeneous [NZBxNZW]F(1) mice. Anti-DNA and anti-Hsp65 antibodies responsiveness was individually measured during the animal's life span, and the mean survival time [MST] was determined. The treatment with WT abbreviates the MST in 46%, when compared to non-treated mice [p<0.001]. An increase in the IgG2a/IgG1 anti-DNA antibodies ratio was also observed in animals injected with the WT Hsp65. Incubation of BALB/c macrophages with F(1) serum from WT treated mice resulted in acute cell necrosis; treatment of these cells with serum from K(409)A treated mice did not cause any toxic effect. Moreover, the involvement of WT correlates with age and is dose-dependent. Our data suggest that Hsp65 may be a central molecule intervening in the progression of the SLE, and that the point mutated K(409)A recombinant immunogenic molecule, that counteracts the deleterious effect of WT, may act mitigating and delaying the development of SLE in treated mice. This study gives new insights into the general biological role of Hsp and the significant impact of environmental factors during the pathogenesis of this autoimmune process.
url http://europepmc.org/articles/PMC2515089?pdf=render
work_keys_str_mv AT elianabmarengo administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT lucianavdemoraes administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT marcellafaria administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT beatrizlfernandes administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT lucianavcarvalho administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT denisevtambourgi administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT luizvrizzo administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT fernandacvportaro administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT antoniocarlosmcamargo administrationofmlepraehsp65interfereswiththemurinelupusprogression
AT osvaldoasantanna administrationofmlepraehsp65interfereswiththemurinelupusprogression
_version_ 1724784687060090880